RxDoctor Payments Data

Chelsea Puente, PA

Physician Assistant · Buffalo, WYNPI 1083044630

Payments from drug & device makers

$349in general payments, 2019–2025

Across 17 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$66
  • Novo Nordisk$58
  • AbbVie$53
  • Astellas Pharma US Inc$33
  • Abbott$29
  • Sanofi-aventis U.S. LLC$23
  • plus $88 from 5 others

What the payments were for

  • Food & beverage$349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$349 in reported general payments places this provider in the 65th percentile of 203 physician assistant providers in Wyoming.

See all physician assistant providers in Wyoming

Medicare billing

Part B allowed, 2024
$14,517
Medicare patients
78
Services billed
211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin47$39,588
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$33,332
OzempicSemaglutide27$27,312
TrulicityDulaglutide11$10,496
MyrbetriqMirabegron15$10,382
EliquisApixaban15$8,524
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$7,208
XareltoRivaroxaban12$6,635
Breo ElliptaFluticasone/Vilanterol12$5,248
SynthroidLevothyroxine Sodium14$1,768
Levothyroxine Sodium133$1,679
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$1,315
Gabapentin66$1,285
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,135
Metoprolol Succinate54$1,119

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$19$38,58052 claims
Novo NordiskOzempic$58$27,31227 claims
Lilly USA, LLCTrulicity$14$10,49611 claims
Astellas Pharma US IncMyrbetriq$33$10,38215 claims
AbbVieSynthroid$53$1,76814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 203 physician assistant providers in Wyoming.

Other physician assistant in Buffalo

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →